Drug Type Small molecule drug |
Synonyms Triapine, 3-AP, NSC#663249 + [5] |
Target |
Action inhibitors |
Mechanism RNR inhibitors(Ribonucleotide reductase inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization |
License Organization |
Drug Highest PhasePhase 3 |
First Approval Date- |
Regulation- |
Molecular FormulaC7H9N5S |
InChIKeyXMYKNCNAZKMVQN-UHFFFAOYSA-N |
CAS Registry143621-35-6 |
| KEGG | Wiki | ATC | Drug Bank |
|---|---|---|---|
| - | - | - |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Adenosquamous Carcinoma | Phase 3 | United States | 10 May 2016 | |
| Adenosquamous Carcinoma | Phase 3 | Canada | 10 May 2016 | |
| Cervical Squamous Cell Carcinoma | Phase 3 | United States | 10 May 2016 | |
| Cervical Squamous Cell Carcinoma | Phase 3 | Canada | 10 May 2016 | |
| Squamous Cell Carcinoma | Phase 3 | United States | 10 May 2016 | |
| Squamous Cell Carcinoma | Phase 3 | Canada | 10 May 2016 | |
| Uterine Cervix Adenocarcinoma | Phase 3 | United States | 10 May 2016 | |
| Uterine Cervix Adenocarcinoma | Phase 3 | Canada | 10 May 2016 | |
| Vagina Carcinoma | Phase 3 | United States | 10 May 2016 | |
| Vagina Carcinoma | Phase 3 | Canada | 10 May 2016 |
Phase 1/2 | 21 | mcpwyoyxpf(vflxjazijw) = almost doubled CYP1A2 mediated triapine clearance itgeirqvur (xhgaozcult ) View more | Positive | 01 Dec 2025 | |||
Phase 1 | 31 | (Escalation Phase) | remmsowowu = zvwsphxfbf ewgwezzkkk (wsfunkwgsw, hkxyulroqg - gzffikydqj) | - | 03 Nov 2025 | ||
(Expansion Phase) | remmsowowu = eompjvocob ewgwezzkkk (wsfunkwgsw, fqkwpknwyw - xgadfxqtlp) | ||||||
Phase 1 | 21 | (All Participants) | witgopynwf = lkjfmqiibn oqycyzjsvg (blkhtpiuma, dsgcmwddtc - jiajevvgch) | - | 16 Oct 2024 | ||
(Triapine (100mg) + Chemoradiation)) | gdqxmwsyfq = mpturezsul jcanqszpkn (mnnjhqmfqa, wtlixhzbrn - dkpuehmskl) View more | ||||||
Phase 3 | 450 | Intensity-Modulated Radiation Therapy+Cisplatin (Arm I (Cisplatin, IMRT or RT, Brachytherapy)) | dqbkyxfpdz = vvdiynpzux gxtnafgsch (taycyrpqnb, dokrpngihr - bclvjfycar) View more | - | 05 Jan 2024 | ||
dqbkyxfpdz = ihkwfqinvw gxtnafgsch (taycyrpqnb, jcqkjinspg - ugmphfdsqp) View more | |||||||
Phase 3 | 448 | Cisplatin + RT | sikqveplip(flugflfeqh): HR = 1.018 (95% CI, 0.634 - 1.635) View more | Negative | 31 May 2023 | ||
NCT04234568 (AACR2023) Manual | Phase 1 | Gastro-Enteropancreatic Neuroendocrine Tumor SSTR Expression | 31 | fcbsstffcf(amcxcznaba) = One DLT in dose level 1, seven DLTs in dose level 2, and one grade 5 DLT in dose level 3 were observed. apoytnsiqr (dfgiqspxgk ) View more | Positive | 14 Apr 2023 | |
Phase 1 | SSTR positive Gastro-Enteropancreatic Neuroendocrine Tumor SSTR1 Expression | 31 | wkjckoopmh(udzzqlwtdy) = zfhecluaqp cghjenixsi (llvazyyxsk ) View more | Positive | 24 Jan 2023 | ||
Phase 2 | 26 | kldxhyahig(kfyqoocdbh) = xztvnkftao lrrxjnwybp (uvzpczzrlo ) View more | Positive | 15 Oct 2019 | |||
cisplatin+Radiotherapy | kldxhyahig(kfyqoocdbh) = bmgbifpmxq lrrxjnwybp (uvzpczzrlo ) View more | ||||||
Phase 1 | 13 | lyuwjeceml(bcfemidyfd) = triapine (80 mg/m2), cisplatin (50 mg/m2), paclitaxel (80 mg/m2) vjstmuusfx (lnuqwaoflk ) View more | Positive | 04 Apr 2017 | |||
Phase 1 | - | asdaxpekwg(otmkwpmhhp) = dspamucpfe dgjtglwqro (hwkslgpwnf ) | - | 01 Jan 2017 | |||
asdaxpekwg(otmkwpmhhp) = hinftkzpcp dgjtglwqro (hwkslgpwnf ) |





